WLSVF is a venture capital fund established to create, acquire, and develop early and later stage human bio/medical technology companies.
The Western Life Sciences Venture Fund LP is a $45 Million ($45 million Tranche) venture capital fund established to create, acquire, and develop early and later stage human bio/medical technology companies. The fund is managed by Lombard Life Sciences.“The mission of the Fund is to provide intellectual and financial capital to emerging life science companies.”The Fund expects thereby:- To create and develop such companies to the point where they qualify for significant public or private market financing, or other strategic partnerships;- To help such companies make their contributions to improving the quality of the world’s health care;- To help such companies make their contribution to decreasing the costs of providing the world’s health care and;- By achieving the above, to provide to the Fund’s investors a very substantial return on their investments.
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
---|---|---|---|---|
May 26, 2015
Rani Therapeutics
|
Series C | $37.10M | Biotechnology | — |